XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration
Investors seeking healthcare exposure must choose between the stability of diversified pharmaceutical giants and the high-growth potential of specialized biotech firms. The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides broad exposure to the healthcare sector at a lower cost, while the iShares Biotechnology ETF (NASDAQ:IBB) focuses on a more volatile niche. This comparison analyzes how these different focuses affect cost, yield, and risk-adjusted performance for long-term holders. Continue reading